OPENBIOME
Live / Applied — Third extension granted (statement of use) (as of 15 Jan 2026)
What this means for you
Not registered yet, but its 21 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98096920
- Mark type
- Stylized text
- Filed
- 21 Jul 2023
- Published for opposition
- 21 May 2024
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for the treatment of cancer, infectious, autoimmune, metabolic, nutrition, gastrointestinal, hepatic, and neuropsychiatric diseases, disorders, and conditions; Pharmaceutical and biological preparations for use in fecal microbiotal transplantation; Therapeutic agents in the form of processed stool biospecimen for use in fecal microbiotal transplantation.
- Class 044 — Medical, beauty and agricultural services: Stool bank services for medical clinical purposes; Medical analysis services, namely, processing of stool for use in medical treatments.
Owner
- OPENBIOME FOUNDATION INC., CAMBRIDGE, MA, US
- Microbiome Health Research Institute Inc., Cambridge, MA, US
- Microbiome Health Research Institute Inc., Cambridge, MA, US
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2026 — SOU EXTENSION 3 GRANTED
- 11 Jan 2026 — SOU EXTENSION 3 FILED
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 06 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2026 — CORRECTED NOA E-MAILED
- 06 Jan 2026 — CORRECTED NOA E-MAILED
- 06 Jan 2026 — SOU EXTENSION 2 GRANTED
- 09 Jul 2025 — SOU EXTENSION 2 FILED
- 06 Jan 2026 — DIVISIONAL PROCESSING COMPLETE
- 10 Jul 2025 — DIVISIONAL REQUEST RECEIVED
- 05 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Aug 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Jul 2025 — TEAS REQUEST TO DIVIDE RECEIVED